Carley Brian T 4

What Happened

• Brian T. Carley, a director of Medpace Holdings, had 36 restricted stock units (RSUs) convert into 36 shares on March 31, 2026. The Form 4 shows a simultaneous reported disposition of 36 shares at $0.00. No cash proceeds are reported for the disposition.
• This is a compensation-related conversion (RSU vesting), not an open-market buy or sell; such conversions are typically routine and related to vesting schedules rather than a trading decision.

Key Details

• Transaction date: 2026-03-31.
• Acquired: 36 shares via conversion of derivative (RSU); Disposed: 36 shares at $0.00 (reported as derivative).
• Price/value: Acquisition listed as N/A; disposition reported at $0.00 (no cash proceeds).
• Shares owned after transaction: Not specified in the provided filing extract.
• Footnotes: F1 clarifies each RSU converts to one share. F2 notes the RSU grant was 143 units on Nov 28, 2025 vesting in four roughly equal installments (Mar 31, Jun 30, Sep 30, Dec 31, 2026).
• Filing timeliness: Report filed Apr 2, 2026 for the Mar 31, 2026 transaction (within the typical 2-business-day Form 4 reporting window).

Context

• RSU conversions occur when restricted stock units vest and are converted into common shares. The matching disposition reported at $0.00 is consistent with shares being withheld or transferred to cover tax withholding or similar obligations (a common practice), resulting in no net cash proceeds and likely little-to-no change in beneficial ownership. The filing does not indicate an open-market sale.